Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30529277 | 0.97 | ALDH1A1 (0.65) | ALDH1A1CA1CA2CA9TSHR | |
| SCHEMBL22445077 | 0.90 | ALDH1A1 (0.65) | ALDH1A1CA1CA2CA9TSHR | |
| SCHEMBL22164058 | 0.82 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL22592522 | 0.81 | ALDH1A1 (0.50) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL17011976 | 0.81 | ALDH1A1 (0.50) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL36444 | 0.81 | ALDH1A1 (0.50) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL6856775 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TSHRSMN1; SMN2TDP1 | |
| SCHEMBL10080567 | 0.79 | ALDH1A1 (0.49) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL8064669 | 0.78 | — | — | |
| SCHEMBL15162 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919919-B2 | Epoxy-functional alkoxysilanes, method for the production and use thereof | EVONIK OPERATIONS GMBH (DE) | 2021-02-16 | — | — | US | disclosed |
| US-20200331937-A1 | Novel epoxy-functional alkoxysilanes, method for the production and use thereof | EVONIK OPERATIONS GMBH (DE) | 2020-10-22 | — | — | US | disclosed |
| WO-2019076594-A1 | NOVEL EPOXY-FUNCTIONAL ALKOXYSILANES, METHOD FOR THE PRODUCTION AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2019-04-25 | — | — | WO | disclosed |
| EP-3473631-A1 | NEW EPOXY-FUNCTIONAL ALKOXYSILANES, METHOD FOR THEIR PREPARATION AND THEIR USE | Evonik Degussa GmbH (DE) | 2019-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919919-B2 | Epoxy-functional alkoxysilanes, method for the production and use thereof | EPX, EPHX2, GNE | ALDH1A1 260/4885CA1 1780/4885CA2 2894/4885 |
| US-20200331937-A1 | Novel epoxy-functional alkoxysilanes, method for the production and use thereof | EPX, EPHX2, GNE | ALDH1A1 237/4885CA1 1630/4885CA2 2978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.